日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

First-Line Systemic Treatment for Initially Unresectable Colorectal Liver Metastases: Post Hoc Analysis of the CAIRO5 Randomized Clinical Trial

一线全身治疗方案用于初始无法切除的结直肠癌肝转移:CAIRO5随机临床试验的事后分析

Bond, Marinde J G; Bolhuis, Karen; Loosveld, Olaf J L; de Groot, Jan Willem B; Droogendijk, Helga; Helgason, Helgi H; Hendriks, Mathijs P; Klaase, Joost M; Kazemier, Geert; Liem, Mike S L; Rijken, Arjen M; Verhoef, Cornelis; de Wilt, Johannes H W; de Jong, Koert P; Gerhards, Michael F; van Amerongen, Martinus J; Engelbrecht, Marc R W; van Lienden, Krijn P; Hermans, John J; Molenaar, I Quintus; Grünhagen, Dirk J; de Valk, Bart; Haberkorn, Brigitte C M; Kerver, Emile D; Erdkamp, Frans; van Alphen, Robbert J; Mathijssen-van Stein, Daniëlle; Komurcu, Aysun; May, Anne M; Swijnenburg, Rutger-Jan; Punt, Cornelis J A

Indolocarbazoles as host-directed therapeutics against intracellular infections by methicillin-resistant Staphylococcus aureus

吲哚咔唑类药物作为宿主导向疗法对抗耐甲氧西林金黄色葡萄球菌的细胞内感染

van den Biggelaar, Robin H G A; Erdkamp, David; de Visser, Adriëtte W; van den Eeden, Susan J F; Saris, Anno

The prognostic impact of BMI in patients with HR+/HER2- advanced breast cancer: a study of the SONABRE registry

BMI对HR+/HER2-晚期乳腺癌患者预后的影响:一项基于SONABRE注册研究的分析

Lammers, Senna W M; Thurisch, Hannah; Vriens, Ingeborg J H; Meegdes, Marissa; Engelen, Sanne M E; Erdkamp, Frans L G; Dercksen, M Wouter; Vriens, Birgit E P J; Aaldering, Kirsten N A; Pepels, Manon J A E; van de Winkel, Linda M H; Peters, Natascha A J B; Tol, Jolien; Heijns, Joan B; van de Wouw, Agnes J; Teeuwen, Nathalie J A; Geurts, Sandra M E; Tjan-Heijnen, Vivianne C G

Time trends in real-world treatment patterns and survival in patients diagnosed with de novo HER2+ metastatic breast cancer: an analysis of the SONABRE registry

SONABRE注册研究分析了新诊断为HER2阳性转移性乳腺癌患者的真实世界治疗模式和生存期的时间趋势。

Geurts, Sandra M E; Ibragimova, Khava I E; Ding, Nan; Meegdes, Marissa; Erdkamp, Frans; Heijns, Joan B; Tol, Jolien; Vriens, Birgit E P J; Dercksen, Marcus W; Aaldering, Kirsten N A; Pepels, Manon J A E; van de Winkel, Linda; Peters, Natascha A J B; van de Wouw, Agnes J; Maaskant, Sabrina A J G; Teeuwen-Dedroog, Nathalie J A; van Nijnatten, Thiemo J A; de Boer, Maaike; Tjan-Heijnen, Vivianne C G

Extended adjuvant aromatase inhibition after sequential endocrine therapy in postmenopausal women with breast cancer: follow-up analysis of the randomised phase 3 DATA trial

绝经后乳腺癌患者序贯内分泌治疗后延长辅助芳香化酶抑制治疗:随机3期DATA试验的随访分析

Tjan-Heijnen, Vivianne C G; Lammers, Senna W M; Geurts, Sandra M E; Vriens, Ingeborg J H; Swinkels, Astrid C P; Smorenburg, Carolien H; van der Sangen, Maurice J C; Kroep, Judith R; de Graaf, Hiltje; Honkoop, Aafke H; Erdkamp, Frans L G; de Roos, Wilfred K; Linn, Sabine C; Imholz, Alexander L T

The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancer

体重指数对激素受体阳性乳腺癌的预后和预测作用

Lammers, Senna W M; Geurts, Sandra M E; van Hellemond, Irene E G; Swinkels, Astrid C P; Smorenburg, Carolien H; van der Sangen, Maurice J C; Kroep, Judith R; de Graaf, Hiltje; Honkoop, Aafke H; Erdkamp, Frans L G; de Roos, Wilfred K; Linn, Sabine C; Imholz, Alexander L T; Smidt, Marjolein L; Vriens, Ingeborg J H; Tjan-Heijnen, Vivianne C G

Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours

度伐利尤单抗治疗错配修复缺陷或微卫星不稳定性高实体瘤患者的疗效、安全性和生物标志物分析

Geurts, Birgit S; Battaglia, Thomas W; van Berge Henegouwen, J Maxime; Zeverijn, Laurien J; de Wit, Gijs F; Hoes, Louisa R; van der Wijngaart, Hanneke; van der Noort, Vincent; Roepman, Paul; de Leng, Wendy W J; Jansen, Anne M L; Opdam, Frans L; de Jonge, Maja J A; Cirkel, Geert A; Labots, Mariette; Hoeben, Ann; Kerver, Emile D; Bins, Adriaan D; Erdkamp, Frans G L; van Rooijen, Johan M; Houtsma, Danny; Hendriks, Mathijs P; de Groot, Jan-Willem B; Verheul, Henk M W; Gelderblom, Hans; Voest, Emile E

Outcomes for the first four lines of therapy in patients with HER2-positive advanced breast cancer: results from the SONABRE registry

HER2阳性晚期乳腺癌患者前四线治疗的疗效:来自SONABRE注册研究的结果

Ibragimova, Khava I E; Geurts, Sandra M E; Meegdes, Marissa; Erdkamp, Frans; Heijns, Joan B; Tol, Jolien; Vriens, Birgit E P J; Dercksen, Marcus W; Aaldering, Kirsten N A; Pepels, Manon J A E; van de Winkel, Linda; Peters, Natascha A J B; Teeuwen-Dedroog, Nathalie J A; Vriens, Ingeborg J H; Tjan-Heijnen, Vivianne C G

Patients with Rare Cancers in the Drug Rediscovery Protocol (DRUP) Benefit from Genomics-Guided Treatment

参与药物再发现方案(DRUP)的罕见癌症患者可从基因组指导治疗中获益。

Hoes, Louisa R; van Berge Henegouwen, Jade M; van der Wijngaart, Hanneke; Zeverijn, Laurien J; van der Velden, Daphne L; van de Haar, Joris; Roepman, Paul; de Leng, Wendy J; Jansen, Anne M L; van Werkhoven, Erik; van der Noort, Vincent; Huitema, Alwin D R; Gort, Eelke H; de Groot, Jan Willem B; Kerver, Emile D; de Groot, Derk Jan; Erdkamp, Frans; Beerepoot, Laurens V; Hendriks, Mathijs P; Smit, Egbert F; van der Graaf, Winette T A; van Herpen, Carla M L; Labots, Mariette; Hoeben, Ann; Morreau, Hans; Lolkema, Martijn P; Cuppen, Edwin; Gelderblom, Hans; Verheul, Henk M W; Voest, Emile E

The implementation of CDK 4/6 inhibitors and its impact on treatment choices in HR+/HER2- advanced breast cancer patients: A study of the Dutch SONABRE Registry

CDK 4/6抑制剂的应用及其对HR+/HER2-晚期乳腺癌患者治疗选择的影响:一项来自荷兰SONABRE注册研究

Meegdes, Marissa; Geurts, Sandra M E; Erdkamp, Frans L G; Dercksen, Marcus Wouter; Vriens, Birgit E P J; Aaldering, Kirsten N A; Pepels, Manon J A E; van de Winkel, Linda M H; Teeuwen, Nathalie J A; de Boer, Maaike; Tjan-Heijnen, Vivianne C G